Optimizing Patient Outcomes in Bipolar Disorder: Long-term Management of Major Depressive Episodes

 

 

PROGRAM OVERVIEW

Bipolar disorder (BD) is a complex illness, and its diagnosis and management remain among the most challenging facets of clinical psychiatry. Patients with bipolar disorder are most likely to present with depression and are often misdiagnosed with unipolar depression. Many patients wait years for a correct diagnosis. Distinguishing between unipolar and bipolar depression (BPD) is often difficult, and the frequent occurrence of mixed features can make the differential diagnosis challenging. Medical and psychiatric comorbidities are also common in patients with bipolar depression and complicate the diagnosis and treatment. Persons with bipolar disorder have a high incidence of metabolic syndrome and other cardiovascular risk factors, while obesity and inactivity are associated with more severe illness and poorer treatment outcomes.  Anxiety disorders and substance use disorder are among the most common psychiatric comorbidities in patients with bipolar disorder. Accurate diagnosis and consideration of comorbidities can prevent inappropriate or ineffective pharmacotherapy.

During this interactive online activity, learners will listen to a brief lecture given by expert faculty on practical patient-centered strategies for diagnosis and management of bipolar depression, considerations for medical and psychiatric comorbidities, and evidence-based treatment strategies for bipolar depression. In this program learners will be able to test their knowledge with questions dispersed throughout the activity.

FACULTY

Leslie L. Citrome, MD, MPH
Clinical Professor
Psychiatry & Behavioral Sciences
New York Medical College
Valhalla, New York

 

Joseph F. Goldberg, MD
Clinical Professor
Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York

 

Release date: August 16, 2021
Expiration date: August 16, 2022
Estimated time to complete activity: 60 minutes

 

TARGET AUDIENCE

This educational initiative is designed for psychiatrists, psychiatric nurse practitioners and physician assistants in the field of bipolar disorder.

LEARNING OBJECTIVES
  • Formulate a differential diagnosis of BD, differentiating BPD from unipolar depression, major depressive disorder, subsyndromal mania/hypomania, and other disorders
  • Propose appropriate and effective treatment for major depressive episodes associated with BD
  • Integrate strategies for treatment of patients with BPD and comorbidities
  • Apply management and patient education recommendations in current clinical practice guidelines to routine care of patients with BD
DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. During the period of August 16, 2021 –August 16, 2022 participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • Study the educational activity
  • Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better.

MEDIA

Internet

ACCREDITATION

Physician Continuing Education

 

Accreditation Statement
Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION

Integrity Continuing Education, Inc. designates this enduring activity for a maximum of 1.o AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education, Inc. at (855) 835-4004 or cme@integrityce.com.

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated.

The following faculty/planners reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of these CME activities:

Leslie Citrome, MD, MPH
Royalty: Elsevier (Topic Editor, Psychiatry, Clinical Therapeutics), Springer Healthcare (book) UpToDate (reviewer), Wiley (Editor-in-Chief, International Journal of Clinical Practice, through end 2019)
Consulting Fees: AbbVie, Acadia, Alkermes, Allergan, Angelini, Astellas, Avanir, Axsome, BioXcel, Boehringer Ingelheim, Cadent Therapeutics, Eisai, Impel, Intra-Cellular Therapies, Janssen, Karuna, Lundbeck, Luye, Lyndra, Medavante-ProPhase, Merck, Neurocrine, Noven, Osmotica, Otsuka, Relmada, Sage, Shire, Sunovion, Takeda, Teva, University of Arizona, and one-off ad hoc consulting for individuals/entities conducting marketing, commercial, or scientific scoping research
Speakers’ Bureaus: AbbVie, Acadia, Alkermes, Allergan, Angelini, Eisai, Intra-Cellular Therapies, Janssen, Lundbeck, Merck, Neurocrine, Noven, Otsuka, Sage, Shire, Sunovion Pharmaceuticals, Inc., Takeda, Teva
Ownership Interest: Stocks (small number of shares of common stock): Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, Merck, Pfizer (purchased > 10 years ago)

Joseph F. Goldberg, MD
Royalty: American Psychiatric Publishing, Cambridge University Press
Consulting Fees: Bioxcel, Lundbeck Pharmaceuticals, Otsuka, Sage Pharmaceuticals, Sunovion
Speakers Bureaus: Allergan, Inter-Cellular Therapies, Sunovion

The Integrity Continuing Education, Inc. planners and managers have nothing to disclose.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)

MINIMUM SYSTEM REQUIREMENTS

Minimum Processor: Intel Pentium 4, 2.33 + GHz (or equivalent)
Operating Systems: Windows XP, Windows 2000, Windows Vista, Windows 7, Windows 10, and Mac OS
Plug-in: Adobe® Flash® Player 10

  • Adobe® Flash® Player 10 plug-in should be downloaded
  • Click on the “Agree and install now” button after unchecking the optional McAfee Security Scan Plus

For optimal performance, the use of Internet Explorer below 8 is not recommended

For a full listing of recommended operating systems, browsers, and system configurations, please click on the link below:
Click here for more information on minimum system requirements

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

PROVIDER STATEMENT

Provided by Integrity Continuing Education, Inc.

SUPPORTER ACKNOWLEDGEMENT

Supported by an educational grant from Sunovion Pharmaceuticals, Inc.

 

Continue to Pretest